The Recall Desk
CriticalFDA (Drugs)·D-1111-2017·Announced 2017-08-30

Phenobarbital Tablets Recalled Due to Incorrect Strength Labeling

C. O. Truxton is recalling Phenobarbital 15 mg tablets that were actually 30 mg due to a labeling error.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classified this recall as FDA Class I, which mandates a severity score of 5 according to the rubric.

Plain-English summary

C. O. Truxton is recalling specific bottles of Phenobarbital Tablets USP, 15 mg, 1000 count. The recall is due to a labeling error where bottles labeled as containing 15 mg tablets actually contained 30 mg tablets.

The affected product is identified by Lot # 70952A and an expiration date of 11/17. The product was distributed nationwide. The agency has classified this recall as Class I.

Consumers should check their medication for the specific lot number and expiration date listed above. If the product matches the description, they should stop using it and contact their healthcare provider or pharmacist for guidance.

The recalled product

Product
Phenobarbital Tablets USP, 15 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6160-10
Manufacturer
C. O. Truxton

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 70952A
  • Exp. 11/17

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 6 recalled by C. O. Truxton under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 6 products in this recall →